PU

Pulmatrix Inc

PULM
Accountable AI Logo

Pulmatrix Inc AI Insights

Informational only. Not investment advice.
As of 2025-12-18

Snapshot

  • Revenue TTM of just 3K with -6.2M operating loss - burning 2,000x revenue annually. Cash runway ~9 months at current burn rate.[Free Cash Flow TTM]
  • Revenue collapsed 91% over 3Y and 81% over 5Y - near-complete business deterioration with minimal commercial activity.[Total Revenue 3Y Growth TTM]
  • Zero debt with 4.7M working capital provides survival buffer, but P/S of 4,528x vs industry median 4.1x signals speculative pricing.[P/S Ratio]

Watch Triggers

  • Cash and Equivalents: Falls below 2M or financing announcedSub-2M cash triggers going concern risk; financing terms reveal dilution magnitude
  • Research and Development TTM: Increases above 500KR&D ramp signals renewed pipeline investment and potential catalyst development
  • Total Revenue TTM: Any meaningful increase above 100KRevenue from near-zero would indicate partnership, licensing, or commercial traction

Bull Case

Clean balance sheet (zero debt, 4.7M equity) and micro-cap status (13.6M market cap) creates binary upside if pipeline advances or acquisition occurs.

Debt to EquityMarket Cap TTMTangible Book Value

Trading at 2.9x book value with 4.8M cash - EV of 8.8M implies market assigns minimal value to IP/pipeline, creating optionality.

P/B RatioEnterprise ValueCash and Equivalents

Bear Case

Near-zero revenue (3K TTM) with 91% 3Y decline indicates failed commercialization. R&D of 47K suggests pipeline is effectively abandoned.

Total Revenue TTMTotal Revenue 3Y Growth TTMResearch and Development TTM

At -6M annual burn, 4.8M cash lasts ~9 months. Dilution or liquidation appears inevitable without external catalyst.

Cash Flow TTMCash and EquivalentsShares Outstanding

Bull vs Bear Balance

AI-generated sentiment analysis based on fundamental metrics and market conditions.

BearBull
20%

Leverage PULM's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.

Take Me to The Editor

Forward Thesis

Cash exhaustion likely within 12 months without dilutive financing or partnership

3-12mhigh
  • 4.8M cash vs -6M annual burn rate
  • R&D spend collapsed to 47K TTM
  • No debt capacity to lever
FCF TTM: -6.0MCash: 4.8M, down from 5.8MZero debt on balance sheet
Valuation Context
Caveats

Public Strategies Rankings

See how Pulmatrix Inc ranks across different investment strategies.

Leverage PULM's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.

Data Partners
Morningstar Logo

Fundamental company data provided by Morningstar, updated daily.

Accountable Finance, Inc. Disclaimer
accountable.finance is not operated by a broker or a dealer. Under no circumstances does any information posted on accountable.finance represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. In no event shall accountable.finance be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on accountable.finance, or relating to the use of, or inability to use, accountable.finance or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Stock quotes and fundamental company data provided by Morningstar, updated daily.

Accountable Logo
© 2025 Accountable Finance, Inc. All rights reserved.